Nerve block vs lidocaine drip: which eases pain after breast reduction?
NCT ID NCT07687069
First seen Jul 07, 2026 · Last updated Jul 08, 2026 · Updated 1 time
Summary
This study compares two ways to manage pain after breast reduction surgery: a nerve block (ESPB) using bupivacaine, and an intravenous lidocaine drip given during surgery. Both aim to reduce pain, lower opioid use, and improve recovery quality. The trial includes 80 women scheduled for non-cancer breast reduction, and measures recovery scores and pain levels in the first 24 hours.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- bupivacaine (nerve block) and lidocaine (intravenous infusion)
- What this could lead to
- If one method proves better or equal, it could simplify pain management after breast reduction, reducing opioid needs and speeding recovery.
- What could go wrong
- This is a small, single-center study (80 people). Results may not apply to all patients, and both methods carry risks like allergic reactions or nerve damage.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST HYPERTROPHY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Locations
-
Centre of Postgraduate Medical Education,Department of Anesthesia and Intensive Care
Warsaw, 01-813, Poland
More trials for these conditions
Other studies related to the condition(s) this trial covers.